Oculis Holding AG
IPOGlobal Biopharmaceutical Company Driven To Save Sight & Improve Eye Care
Public · Reykjavik, Switzerland · Founded 2017 · $92.9M raised
- Headquarters
- Reykjavik
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- oculis.com
- Total Funding
- $92.9M
- Last Round
- $57.0M Series CMay 2021
- Rounds
- 3
- Type
- Public
About
Oculis Holding AG is a global biopharmaceutical company developing differentiated therapies for neuro-ophthalmic and ophthalmic diseases. Its pipeline includes Privosegtor, a peptoid small molecule designed to cross the blood-brain and retinal barriers as a potential first neuroprotective therapy for optic neuritis and NAION, and Licaminlimab, an anti-TNFα eye drop candidate for dry eye disease using a precision medicine approach. The company is advancing registrational trials and aims to change treatment paradigms for patients facing permanent visual impairment.
Summary
Oculis Holding AG is a Biotech company based in Reykjavik, Switzerland, founded in 2017. It has raised $92.9M in total across 3 rounds, most recently a $57.0M Series C round in May 2021. Investors include Brunnur Ventures, Earlybird Venture Capital and Bay City Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2021
Sign up to see all 3 rounds
Series B through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oculis-holding-ag"><img src="https://indexed.vc/api/badge/company/oculis-holding-ag" alt="Oculis Holding AG on Indexed.vc" width="260" height="76" /></a>